Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2008

Dec 5, 2008

34975_dirs_2008-12-05_639b5db3-515e-4f13-93b8-3a076d7c870d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2008-12-04

Reporting Person: GRAZIANO CHANE (Director, Chief Executive Officer, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-12-04 Stock Option (Right to buy) $1.99 A 300000 Disposed 2018-12-04 Common Stock, par value $0.01 per share (300000) Direct

Footnotes

F1: The shares vest in four equal installments on the first four anniversaries of January 1, 2008.